Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | galactosidase, alpha | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 0.1993 | 0.3145 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0126 | 0.1993 | 0.1796 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0124 | 0.1948 | 0.5147 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.036 | 0.6282 | 1 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0224 | 0.3785 | 0.6009 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0082 | 0.1192 | 0.3149 |
Onchocerca volvulus | 0.0252 | 0.4294 | 1 | |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0124 | 0.1948 | 0.5147 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0051 | 0.0619 | 0.0949 |
Echinococcus multilocularis | serotonin receptor | 0.0126 | 0.1993 | 0.1778 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.026 | 0.0376 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.038 | 0.1004 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.026 | 0.1337 |
Brugia malayi | hypothetical protein | 0.0251 | 0.4286 | 0.681 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0251 | 0.4286 | 0.4133 |
Brugia malayi | Pre-SET motif family protein | 0.0221 | 0.3734 | 0.5927 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1192 | 0.1865 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0563 | 1 | 1 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0281 | 0.4836 | 0.769 |
Brugia malayi | hypothetical protein | 0.0103 | 0.1566 | 0.2464 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.026 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.026 | 0.0022 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0221 | 0.3734 | 0.5927 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.036 | 0.6282 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0126 | 0.1993 | 0.1778 |
Trichomonas vaginalis | set domain proteins, putative | 0.0252 | 0.4294 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.3054 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 0.1993 | 0.3145 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.038 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.6282 | 1 |
Brugia malayi | hypothetical protein | 0.0038 | 0.038 | 0.0567 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.038 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.038 | 0.0144 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 0.4286 | 0.681 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0563 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.026 | 0.0688 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0251 | 0.4286 | 0.4146 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.038 | 0.5 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0124 | 0.1948 | 0.1751 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0224 | 0.3785 | 0.3632 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0224 | 0.3785 | 1 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0124 | 0.1948 | 0.1733 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0082 | 0.1192 | 0.3149 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.026 | 0.0688 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0124 | 0.1948 | 0.5147 |
Brugia malayi | Melibiase family protein | 0.0082 | 0.1192 | 0.1865 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.038 | 0.1004 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0224 | 0.3785 | 0.3618 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.038 | 0.5 |
Toxoplasma gondii | melibiase subfamily protein | 0.0124 | 0.1948 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.026 | 0.0688 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0563 | 1 | 1 |
Onchocerca volvulus | 0.0051 | 0.0619 | 0.0888 | |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0019 | 0.0025 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0126 | 0.1993 | 0.5265 |
Schistosoma mansoni | survival motor neuron protein | 0.0051 | 0.0619 | 0.1634 |
Brugia malayi | follicle stimulating hormone receptor | 0.0281 | 0.4836 | 0.769 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0619 | 0.1634 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.036 | 0.6282 | 1 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0124 | 0.1948 | 0.1733 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.038 | 0.0123 |
Leishmania major | C-8 sterol isomerase-like protein | 0.036 | 0.6282 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0124 | 0.1948 | 0.5147 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.026 | 0.0376 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.026 | 0.0688 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.9285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 1.8526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.